T1	Participants 63 78	septic patients
T2	Participants 350 388	Forty-four patients with severe sepsis
T3	Participants 693 760	were compared between the control group and the hemoperfusion group
T4	Participants 1066 1104	Patients treated with HA hemoperfusion
T5	Participants 1188 1212	Patients in the HA group
T6	Participants 1434 1499	no significant difference between the groups in organ dysfunction
T7	Participants 1651 1695	no significant difference between the groups
T8	Participants 2119 2176	may contribute to improving a patient's outcome in an ICU
